Notes / Company

Thyrocare Technologies Ltd.

THYROCARE BSE 539871 ISIN INE594H01019 Diagnostics

Fundamentals

Market cap: ₹8,232 cr
P/E: 50.37×
ROE: 27.91%
Debt / equity: 0.00
Div yield: 2.51%
52-week range: 321.27 — 578.25

Research on Tijori Finance

Company snapshot

Thyrocare Technologies Ltd.

Diagnostic Chains

₹9,287 cr

P/E 52.68×

Latest quarter · Jun 2026

Sales₹240 cr

Net profit₹51 cr

Op. margin+32.2%

EPS₹3.28

Strength & growth

Debt / equity0.00×

Current ratio3.39×

Sales CAGR+13.2%

EPS CAGR+11.6%

The timeline — 1 note on Thyrocare Technologies Ltd.

July 2026

27 Jul 26 · 1:10 PM IST Brief

Brief · Earnings · Mid cap

Thyrocare's Q1 transcript confirms 24% revenue growth, 34% PAT rise

The transcript of Thyrocare's Q1 FY27 earnings call adds no surprises but reaffirms the company's guidance of mid-to-high teens revenue growth for the year.

Verify on exchange BSE filings for THYROCARE NSE filings for THYROCARE Tijori Finance company page